Glaucoma costs in Denmark in treatment naive patients.
Acta Ophthalmol
; 91(1): 25-31, 2013 Feb.
Article
en En
| MEDLINE
| ID: mdl-21834919
ABSTRACT
PURPOSE:
To describe the costs and providers of glaucoma treatment in Denmark.METHODS:
Analyses were based on National Register data. Glaucoma/OHT patients were identified by their first prescription for glaucoma medication (ATC-codes) in the Danish Register of Medicinal Product Statistics 2002-2007. Patients had used no glaucoma medication for 6 months. Data for 2007 were sampled cross-sectionally for a budgetary analysis of glaucoma (ICD10 code) medication and services consumed in the primary and secondary health care services. Patients were categorized according to their number of treatment changes.RESULTS:
The Danish annual incidence rate of glaucoma was estimated at 1.2 per 1000 adult persons. Thirty-seven per cent of patients (men 44%, mean age 68 years; women 56%, mean age 71 years) persisted with their initial treatment regimen, 21% had changed to a second regimen, and 43% had experienced ≥ 3 regimens. Treatment costs increased with the number of sequential regimens. Annual glaucoma costs (health care sector perspective) were 305 for patients under their initial regimen, increasing to 740 with ≥ 3 regimens. Drug costs accounted for 57% of total cost.CONCLUSIONS:
Drugs represented the major cost of glaucoma, and those costs increased, obviously, with the number of treatment changes.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Contexto en salud:
1_ASSA2030
Problema de salud:
1_financiamento_saude
Asunto principal:
Glaucoma
/
Costos de la Atención en Salud
Tipo de estudio:
Health_economic_evaluation
/
Incidence_studies
/
Prognostic_studies
Límite:
Aged
/
Female
/
Humans
/
Male
País/Región como asunto:
Europa
Idioma:
En
Revista:
Acta Ophthalmol
Asunto de la revista:
OFTALMOLOGIA
Año:
2013
Tipo del documento:
Article
País de afiliación:
Dinamarca